TAK-259

N/A

Report date: 2024/10/17 17:05:42
NME

Base Information

Drug NameTAK-259
Drug Alias NameTAK-259
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenoceptor Alpha 1D antagonists
TargetsAdrenoceptor Alpha 1D
Therapy Area/IndicationsUrinary Bladder, Overactive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTakeda Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsUrinary Bladder, Overactive

Other Information

ATC CodeN/A
Related LinksN/A